Levitate Secures $15 Million in Series D Round to Expand Relationship-Based Business Solutions

Levitate, Levitate, the acclaimed SaaS provider renowned for its ‘Happiness Platform’ tailored for relationship-driven enterprises, has successfully concluded its Series D funding round, securing $15 million. This new influx of capital, led by Harbert Growth Partners, Northwestern Mutual Future Ventures, and Bull City Venture Partners, will enable Levitate to enhance its innovative offerings and extend…

Read More

Citibox Secures €80M to Revolutionize E-commerce Delivery Efficiency Across Spain

Spanish startup Citibox has successfully raised €80 million in debt funding, led by Growth Credit Partners (London) and CoVenture (New York), marking a significant milestone in its mission to expand its network of smart mailboxes throughout Spain. Founded in 2016, Citibox specializes in smart mailbox solutions installed within residential buildings, ensuring successful postal deliveries and…

Read More

NephroDI Therapeutics Secures Strategic Investment to Propel Innovative Therapy for Pediatric Kidney Disease

NephroDI Therapeutics (NephroDI), a leading near-clinical stage pharmaceutical company specializing in kidney disorders, proudly announces a significant Series A investment from life sciences venture capital firm Sound Bioventures. This latest infusion of capital, in tandem with a previously established strategic corporate partnership, is set to advance the development of NDI-5001, a groundbreaking small molecule AMPK…

Read More

X-Bow Secures Over $70 Million in Series B Funding to Propel Hypersonic and Solid Rocket Motor Innovations

X-Bow Systems Inc. (X-Bow), a pioneering force in advanced manufactured solid rocket motors (SRMs) and hypersonics technologies, announced today the successful completion of its Series B financing round, raising in excess of $70 million. This significant capital infusion, led by National Security technology-focused firm Razor’s Edge, alongside contributions from Lockheed Martin Ventures, Boeing Ventures, Crosslink…

Read More

Cartken Secures $22.5M Funding to Pioneer Autonomous Navigation Technology

Cartken, a trailblazing robotics navigation software startup founded in Germany, has announced a significant funding milestone, raising $22.5 million to propel its advancements in autonomous navigation. The latest financing round, including a substantial $10 million injection, underscores Cartken’s commitment to revolutionizing industrial automation and last-mile delivery solutions. Cartken’s cutting-edge technology merges AI and computer vision…

Read More

Quantiphi Honored with AIFinTech100 Recognition for Fourth Consecutive Year

Quantiphi, a pioneering AI-first digital engineering firm, has once again secured its position among the elite in financial technology innovation with its fourth consecutive recognition by AIFinTech100. This prestigious accolade acknowledges Quantiphi’s steadfast commitment to revolutionizing the financial services landscape through cutting-edge AI technologies. AIFinTech100, renowned for its meticulous selection process led by industry experts…

Read More

Hi-Dolphin COFE+: Pioneering the Future of Coffee with Innovation and Global Impact

In a groundbreaking achievement for Shanghai’s technological landscape, Hi-Dolphin COFE+ has once again made headlines by swiftly securing its Series A second round of financing within a single week. This feat, spearheaded by an esteemed family fund, underscores not only the company’s meteoric rise but also the resounding confidence of investors in its disruptive vision….

Read More

DataCore Secures US$60 Million to Propel Innovation in Data Management

DataCore Software, a trailblazer in data infrastructure and management, has marked a significant stride by raising US$60 million in a financing round spearheaded by Vistara Growth. This financing underscores DataCore’s pivotal role in reshaping data ecosystems with AI-driven advancements spanning core, edge, and cloud deployments. The infusion of capital from Vistara Growth, renowned for its…

Read More

AusperBio Secures $37 Million Series A Funding to Accelerate Development of Hepatitis B Therapy

AusperBio Therapeutics, Inc., a pioneering biotechnology firm focused on targeted oligonucleotide therapies for chronic hepatitis B (CHB), has announced the successful completion of a $37 million Series A financing round. This funding, spearheaded by existing investor InnoPinnacle Fund and bolstered by new investors including Yuanbio Venture Capital, Qiming Venture Partners, Hankang Capital, and Genesis Capital,…

Read More